Lv71
4925 积分 2022-10-28 加入
Targeted Degradation of CDK2: A New Strategy for Overcoming Cyclin E‑Driven Cancers
4分钟前
已关闭
Culmerciclib: First Approval
5分钟前
已完结
CDK4/6-targeted therapy: From clinical inhibitors to emerging strategies to overcome resistance
6分钟前
已完结
Novel Compounds as CDK4 Inhibitors for Treating Breast Cancer
7分钟前
求助中
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer
8分钟前
已完结
Cyclin-dependent kinases as therapeutic targets in cancer: Recent advances, challenges, and opportunities
15分钟前
已完结
Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms
16分钟前
已完结
Next-Generation CDK Inhibitors in Breast Cancer: Expanding the Therapeutic Landscape beyond CDK4/6 Inhibitors
17分钟前
求助中
Ring Expansions of 1,2-Amino Alcohols to Amine Heterocycles Enabled by Proton-Coupled Electron Transfer
5天前
已完结
AI-Guided Conformational Dynamics of p53 L1 Loop Reveal an Allosteric Switch Regulating DNA Binding and Cancer Hotspots
3个月前
已完结
皖公网安备34019202002308
